FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Sep 23

PMID 26393353

Citations 14

Authors

Yogesh K Chutake

Whitney N Costello

Christina C Lam

Aniruddha C Parikh

Tamara T Hughes

Michael G Michalopulos

Mark A Pook

Sanjay I Bidichandani

Affiliations

Soon will be listed here.

Abstract

Background: Friedreich ataxia is caused by an expanded GAA triplet-repeat sequence in intron 1 of the FXN gene that results in epigenetic silencing of the FXN promoter. This silencing mechanism is seen in patient-derived lymphoblastoid cells but it remains unknown if it is a widespread phenomenon affecting multiple cell types and tissues.

Methodology / Principal Findings: The humanized mouse model of Friedreich ataxia (YG8sR), which carries a single transgenic insert of the human FXN gene with an expanded GAA triplet-repeat in intron 1, is deficient for FXN transcript when compared to an isogenic transgenic mouse lacking the expanded repeat (Y47R). We found that in YG8sR the deficiency of FXN transcript extended both upstream and downstream of the expanded GAA triplet-repeat, suggestive of deficient transcriptional initiation. This pattern of deficiency was seen in all tissues tested, irrespective of whether they are known to be affected or spared in disease pathogenesis, in both neuronal and non-neuronal tissues, and in cultured primary fibroblasts. FXN promoter function was directly measured via metabolic labeling of newly synthesized transcripts in fibroblasts, which revealed that the YG8sR mouse was significantly deficient in transcriptional initiation compared to the Y47R mouse.

Conclusions / Significance: Deficient transcriptional initiation accounts for FXN transcriptional deficiency in the humanized mouse model of Friedreich ataxia, similar to patient-derived cells, and the mechanism underlying promoter silencing in Friedreich ataxia is widespread across multiple cell types and tissues.

Citing Articles

Triplex H-DNA structure: the long and winding road from the discovery to its role in human disease.

Hisey J, Masnovo C, Mirkin S NAR Mol Med. 2024; 1(4):ugae024.

PMID: 39723156 PMC: 11667243. DOI: 10.1093/narmme/ugae024.

Anatomical and functional analysis of the corticospinal tract in an FRDA mouse model.

Nishiyama M, Kalambogias J, Imai F, Yang E, Lang S, de Nooij J bioRxiv. 2024; .

PMID: 39005321 PMC: 11244874. DOI: 10.1101/2024.06.28.601178.

Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohort.

Lynch D, Rojsajjakul T, Subramony S, Perlman S, Keita M, Mesaros C J Neurol. 2023; 271(4):1844-1849.

PMID: 38063871 DOI: 10.1007/s00415-023-12118-x.

A new FRDA mouse model [ :YG8s(GAA) > 800] with more than 800 GAA repeats.

Kalef-Ezra E, Edzeamey F, Valle A, Khonsari H, Kleine P, Oggianu C Front Neurosci. 2023; 17:930422.

PMID: 36777637 PMC: 9909538. DOI: 10.3389/fnins.2023.930422.

Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice.

Kilikevicius A, Wang J, Shen X, Rigo F, Prakash T, Napierala M RNA Biol. 2022; 19(1):364-372.

PMID: 35289725 PMC: 8928816. DOI: 10.1080/15476286.2022.2043650.

References

Chutake Y, Costello W, Lam C, Bidichandani S . Altered nucleosome positioning at the transcription start site and deficient transcriptional initiation in Friedreich ataxia. J Biol Chem. 2014; 289(22):15194-202. PMC: 4140879. DOI: 10.1074/jbc.M114.566414. View

Colin F, Martelli A, Clemancey M, Latour J, Gambarelli S, Zeppieri L . Mammalian frataxin controls sulfur production and iron entry during de novo Fe4S4 cluster assembly. J Am Chem Soc. 2012; 135(2):733-40. DOI: 10.1021/ja308736e. View

Kim E, Napierala M, Dent S . Hyperexpansion of GAA repeats affects post-initiation steps of FXN transcription in Friedreich's ataxia. Nucleic Acids Res. 2011; 39(19):8366-77. PMC: 3201871. DOI: 10.1093/nar/gkr542. View

Kumari D, Biacsi R, Usdin K . Repeat expansion affects both transcription initiation and elongation in friedreich ataxia cells. J Biol Chem. 2010; 286(6):4209-15. PMC: 3039332. DOI: 10.1074/jbc.M110.194035. View

Bridwell-Rabb J, Fox N, Tsai C, Winn A, Barondeau D . Human frataxin activates Fe-S cluster biosynthesis by facilitating sulfur transfer chemistry. Biochemistry. 2014; 53(30):4904-13. PMC: 4215901. DOI: 10.1021/bi500532e. View

Herman D, Jenssen K, Burnett R, Soragni E, Perlman S, Gottesfeld J . Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol. 2006; 2(10):551-8. DOI: 10.1038/nchembio815. View

Metz G, Coppard N, Cooper J, Delatycki M, Durr A, Di Prospero N . Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database. Brain. 2013; 136(Pt 1):259-68. PMC: 3624678. DOI: 10.1093/brain/aws309. View

Regner S, Wilcox N, Friedman L, Seyer L, Schadt K, Brigatti K . Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants. J Child Neurol. 2012; 27(9):1152-8. PMC: 3674496. DOI: 10.1177/0883073812448462. View

Castaldo I, Pinelli M, Monticelli A, Acquaviva F, Giacchetti M, Filla A . DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients. J Med Genet. 2008; 45(12):808-12. DOI: 10.1136/jmg.2008.058594. View

10.

Sakamoto N, Ohshima K, Montermini L, Pandolfo M, Wells R . Sticky DNA, a self-associated complex formed at long GAA*TTC repeats in intron 1 of the frataxin gene, inhibits transcription. J Biol Chem. 2001; 276(29):27171-7. DOI: 10.1074/jbc.M101879200. View

11.

Anjomani Virmouni S, Ezzatizadeh V, Sandi C, Sandi M, Al-Mahdawi S, Chutake Y . A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia. Dis Model Mech. 2015; 8(3):225-35. PMC: 4348561. DOI: 10.1242/dmm.018952. View

12.

Greene E, Mahishi L, Entezam A, Kumari D, Usdin K . Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia. Nucleic Acids Res. 2007; 35(10):3383-90. PMC: 1904289. DOI: 10.1093/nar/gkm271. View

13.

Durr A, Cossee M, Agid Y, Campuzano V, Mignard C, Penet C . Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med. 1996; 335(16):1169-75. DOI: 10.1056/NEJM199610173351601. View

14.

Evans-Galea M, Carrodus N, Rowley S, Corben L, Tai G, Saffery R . FXN methylation predicts expression and clinical outcome in Friedreich ataxia. Ann Neurol. 2012; 71(4):487-97. DOI: 10.1002/ana.22671. View

15.

Wojdacz T, Dobrovic A, Hansen L . Methylation-sensitive high-resolution melting. Nat Protoc. 2009; 3(12):1903-8. DOI: 10.1038/nprot.2008.191. View

16.

Filla A, De Michele G, Cavalcanti F, Pianese L, Monticelli A, Campanella G . The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet. 1996; 59(3):554-60. PMC: 1914893. View

17.

Sandi C, Mouro Pinto R, Al-Mahdawi S, Ezzatizadeh V, Barnes G, Jones S . Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model. Neurobiol Dis. 2011; 42(3):496-505. PMC: 3107941. DOI: 10.1016/j.nbd.2011.02.016. View

18.

Bidichandani S, Ashizawa T, Patel P . The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am J Hum Genet. 1998; 62(1):111-21. PMC: 1376805. DOI: 10.1086/301680. View

19.

Saveliev A, Everett C, Sharpe T, Webster Z, Festenstein R . DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing. Nature. 2003; 422(6934):909-13. DOI: 10.1038/nature01596. View

20.

Punga T, Buhler M . Long intronic GAA repeats causing Friedreich ataxia impede transcription elongation. EMBO Mol Med. 2010; 2(4):120-9. PMC: 3377279. DOI: 10.1002/emmm.201000064. View